sherif ibrahim
isherif's web site
(email)
Heparan Sulfate Proteoglycans in Cancer Therapy
View
What links here
Citation:
Gassar, E. S., S. A. Ibrahim, and M. Götte, "Heparan Sulfate Proteoglycans in Cancer Therapy", Glycans in Diseases and Therapeutics: springer link, 2011.
Export
RTF
Tagged
XML
BibTex
Google Scholar
Announcements
Publications
Bio
Classes
Links
Calendar
People
Biography_Ibrahim SA
Ibrahim SA_CV
http://link.springer.com/article/10.1007/s13277-016-5137-4
http://link.springer.com/chapter/10.1007/978-3-642-16833-8_6
http://www.ncbi.nlm.nih.gov/pubmed/20818426
http://www.ncbi.nlm.nih.gov/pubmed/22573479
http://www.ncbi.nlm.nih.gov/pubmed/23289672
http://www.ncbi.nlm.nih.gov/pubmed/24392029
http://www.ncbi.nlm.nih.gov/pubmed/24462576
http://www.ncbi.nlm.nih.gov/pubmed/24752740
http://www.ncbi.nlm.nih.gov/pubmed/25168226
http://www.ncbi.nlm.nih.gov/pubmed/?term=Ibrahim+SA[author]+Mohamed+MM
http://www.sciencedirect.com/science/article/pii/S2090123216300467
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0250642
https://link.springer.com/chapter/10.1007/978-3-030-73453-4_12
https://pubmed.ncbi.nlm.nih.gov/32367652/
https://pubmed.ncbi.nlm.nih.gov/32573871/
https://pubmed.ncbi.nlm.nih.gov/32961706/
https://pubmed.ncbi.nlm.nih.gov/34830377/
https://pubmed.ncbi.nlm.nih.gov/34830377/
https://pubmed.ncbi.nlm.nih.gov/34976811/
https://pubmed.ncbi.nlm.nih.gov/36937444/
https://pubmed.ncbi.nlm.nih.gov/36937444/
https://pubmed.ncbi.nlm.nih.gov/37088795/
https://pubs.acs.org/doi/10.1021/acsomega.8b03131?__cf_chl_jschl_tk__=c4ad1796b287cfd06337889d43392d9fd37351c1-1586883874-0-AdCx
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.803899/full
https://www.ingentaconnect.com/content/ben/lddd/2022/00000019/00000011/art00007
https://www.ncbi.nlm.nih.gov/pubmed/28270211
https://www.ncbi.nlm.nih.gov/pubmed/30468236
https://www.ncbi.nlm.nih.gov/pubmed/30572045
https://www.tandfonline.com/doi/abs/10.1080/10406638.2022.2046616
Recent Publications
Anticancer Activity of New Bis-(3-(Thiophen-2-yl)-1H-Pyrazol-4-yl)Chalcones: Synthesis, in-Silico, and in-Vitro Studies
Tumor suppressor miR-218 directly targets epidermal growth factor receptor (EGFR) expression in triple-negative breast cancer, sensitizing cells to irradiation
Editorial: Cancer stem cells as attractive targets for breast cancer therapy
Editorial: Cancer stem cells as attractive targets for breast cancer therapy
Differential Impact of Membrane-Bound and Soluble Forms of the Prognostic Marker Syndecan-1 on the Invasiveness, Migration, Apoptosis, and Proliferation of Cervical Cancer Cells
more
Tourism
